Vivanza Biosciences Ltd

NSE: VIVANZA · BSE: 530057 · Pharmaceuticals & Biotechnology · 20 announcements

Share price: ₹1.70
Market cap: ₹6.80 Cr
Revenue (annual): ₹115.9 Cr
Net profit (annual): ₹0.39 Cr
P/E (TTM): 15.0×Sector 47.3×
Promoter holding: 20.02%+0.00% QoQ
FII holding: 0.00%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Board Meeting Date 5 Other Announcement 3 Financial Results 3 Management Change 2 Fund Raise 1 Debt & Borrowing 1 Business Update 1 Board Meeting Outcome 1 Annual Report 1 Annual General Meeting 1

Time

All time Last 1 week Last 1 month Last 2 months Last 3 months Last 6 months Last 1 year

1 announcement with these filters

19 Aug 2026 11:45 IST BSE

Annual Report

Vivanza Biosciences Annual Report

Vivanza Biosciences Limited has scheduled its 44th Annual General Meeting for September 11, 2026. The company also released its full Annual Report for the financial year 2025-26.

Read the filing ↗